<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>MRC Centre for Inflammation Research</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/36B6C31F-AEF8-46B4-A57A-EE690EC04394"><gtr:id>36B6C31F-AEF8-46B4-A57A-EE690EC04394</gtr:id><gtr:firstName>Kev</gtr:firstName><gtr:surname>Dhaliwal</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601401"><gtr:id>04E12598-760A-4EF1-ABC1-8D2778C72470</gtr:id><gtr:title>MONOCYTE-BASED GENE THERAPY FOR ACUTE NEUTROPHIL-MEDIATED TISSUE INJURY</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0601401</gtr:grantReference><gtr:abstractText>This proposal is aimed at developing new treatments for lung diseases caused by excessive activation of cells used by the body to fight infection (neutrophils). In particular, a condition called adult respiratory distress syndrome is fatal in 40% of cases despite modern treatment, and survivors have considerable long-term problems.. 
The research involves manipulating another defence cell, the monocyte. Monocytes are recruited to inflamed sites alongside neutrophils and are amenable to therapeutic modification. I shall boost monocytes by providing extra copies of a protective gene called elafin. Elafin efficiently neutralises the main toxic product of neutrophils and makes monocytes switch off inflammation. I shall therefore insert elafin into human monocytes in order to reduce the toxic effects of ?activated? neutrophils. I shall extend these findings to mice with the aim of reducing lung injury caused by neutrophils. These pre-clinical studies will lay the grounds for future clinical application in humans. Importantly, the principles of this proposal can be extended not only to other lung diseases associated with neutrophil malfunction (e.g. emphysema, bronchitis, cystic fibrosis) but to all causes of inflammation involving the neutrophil. The work therefore has potential implications for psoriasis, arthritis, peritonitis, and a host of other conditions</gtr:abstractText><gtr:technicalSummary>Neutrophil-mediated lung injury (NMLI) is central to the pathogenesis of conditions such as acute
lung injury and adult respiratory distress syndrome (ARDS). Mortality from these conditions
approaches 40%. Therefore new neutrophil-directed therapeutic strategies are required. Human
neutrophil elastase (HNE) is the key effector of NMLI. Because monocytes specifically access
inflamed alveoli, manipulation of circulating monocytes to express anti-elastases(such as secretory leukocyte protease inhibitor (SLPI) and elafin) has therapeutic potential. I propose that antielastase production by native monocytes is negligible, that monocytes mature into antielastase expressing macrophages in the inflamed lung,that this defence mechanism is overwhelmed in ARDS, and that genetic augmentation of antielastases in monocytes can obviate NMLI. In support of this I have demonstrated novel and consistent protective effects mediated by alveolar macrophages (AMs) but not monocytes against neutrophil-mediated epithelial injury in vitro. This protective effect by AMs is temporally associated with an increase in SLPI secretion. Against this background I aim to address
three key hypotheses:
1. Interaction with neutrophils specifically stimulates generation of protective levels of SLPI from
autologous AMs but not autologous blood monocytes in vitro.
2. Monocytes transfected with adenovirus encoding human elafin (Ad-elafin) consistently protects the lung against neutrophil-mediated injury in vitro and in vivo.
3. Adoptively transferred monocytes traffic rapidly and selectively to the inflamed lung where they differentiate to a macrophage phenotype capable of expressing SLPI. Using primary autologous cells isolated from healthy volunteers and patients with ARDS, I shall assess whether protective effects of AMs on NMLI are SLPI-dependent by transfecting AMs with SLPI siRNA. Human monocytes will be transfected with Ad-elafin to confer consistent protection in vitro.
Extending these studies to an in vivo setting, murine monocytes will be transfected with elafin and adoptively transferred to mice with established NMLI. In the same model, trafficking of adoptively administered monocytes will be assessed dynamically and non-invasively using ?fluorine? MRI. To determine the fate of the administered cells, I will administer monocytes isolated from transgenic GFP mice, then isolate these cells to determine phenotype.
This project offers unique training opportunities in cell and molecular biology, gene therapy, animal models of lung inflammation and ?cutting edge? imaging techniques. From a scientific perspective the proposal will dissect mechanisms by which monocytes and macrophages interact with neutrophils in vitro and in vivo. The development of a novel, targeted ?monocyte-based gene therapy? approach provides a potential strategy for the future treatment of NMLI.</gtr:technicalSummary><gtr:fund><gtr:end>2010-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>145835</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Chemistry</gtr:department><gtr:description>Molecular imaging probe generation</gtr:description><gtr:id>25555595-6DE0-4833-94E6-9514C3833971</gtr:id><gtr:impact>further MRC DPFS award- 625K 
Wellcome Trust HICF award- &amp;pound;2M
University Spin-Off company</gtr:impact><gtr:outcomeId>DCDCF1C54AF-1</gtr:outcomeId><gtr:partnerContribution>Developing optical molecular imaging reagents and tools for applcation in animals and man</gtr:partnerContribution><gtr:piContribution>I run all of the in vivo optical molecular imaging and train new members of staff</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>visit to GSK and Astra Zeneca</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>56568585-63F7-4E9F-A7F8-029EE73BF5A9</gtr:id><gtr:impact>spoke to diverse groups in pharma

collaborations established</gtr:impact><gtr:outcomeId>kopHUCGREA2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>375000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The Sir Jules Thorn Charitable Trust, Project Grant, Clinical Trial</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>Sir Jules Thorn Charitable Trust</gtr:fundingOrg><gtr:id>87727DE8-593E-46C6-BBBA-709799D55739</gtr:id><gtr:outcomeId>6B275ACABB90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>625000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Developmental Pathway Funding Scheme (DPFS)</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>F13C95A8-C7C3-4543-92C7-3DAD9EDC8D41</gtr:id><gtr:outcomeId>89EDBCBD4B60</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>750000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Models of Disease (multimodal imaging of inflammation)</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>954AD8EE-F3E7-48F9-9F4A-807B277C71C2</gtr:id><gtr:outcomeId>A9955CFA5660</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust HICF award- optical imaging in lung infection/inflammation</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>19E5EF0B-27B3-4D58-987B-89CD03467EB1</gtr:id><gtr:outcomeId>rV4WQQ9HyT10</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Preclinical imaging for college of medicine</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>1C43EE61-2F6F-4B8F-9627-2EE84A3F0289</gtr:id><gtr:outcomeId>KhQrT1bGdbX</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Tendering, assessemnet and training the institute to use new equipment to expedite preclinical in vivo imaging</gtr:description><gtr:id>F0911140-43FD-44BE-B911-254321868390</gtr:id><gtr:impact>potential collaborations</gtr:impact><gtr:outcomeId>3BDB830FC79</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Establishing an in vivo optical imaging facility</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Chemical agent that detects protease activity in vitro and in vivo</gtr:description><gtr:id>BBF877C9-016F-4103-BDF5-4810B165085C</gtr:id><gtr:impact>Applied for further funding</gtr:impact><gtr:outcomeId>DE44DA86B6C</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Protease detector</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E9A173A0-9FDB-4063-959B-ACE313C04367</gtr:id><gtr:title>A randomized controlled trial of peripheral blood mononuclear cell depletion in experimental human lung inflammation.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc797cd3a172aa8fe324b25328d15fb5"><gtr:id>dc797cd3a172aa8fe324b25328d15fb5</gtr:id><gtr:otherNames>Barr LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_16194_24_23627345</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A7E0F2B-2BE3-4C5E-A0CB-D85F135E0CD8</gtr:id><gtr:title>C5a-mediated neutrophil dysfunction is RhoA-dependent and predicts infection in critically ill patients.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c79e4ecd48d3bd6b726a973471df2547"><gtr:id>c79e4ecd48d3bd6b726a973471df2547</gtr:id><gtr:otherNames>Morris AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>fyRq3NpLuoj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4D5A90F-C5B1-4438-9BC8-130029758BA6</gtr:id><gtr:title>Technical advance: autofluorescence-based sorting: rapid and nonperturbing isolation of ultrapure neutrophils to determine cytokine production.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/994f32bbf7680bf25a2c8c6d4d577a6e"><gtr:id>994f32bbf7680bf25a2c8c6d4d577a6e</gtr:id><gtr:otherNames>Dorward DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn><gtr:outcomeId>pm_16194_24_23667167</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>167BEE69-1D05-4AF2-8ACB-3640A668AF38</gtr:id><gtr:title>Imaging inflammation: molecular strategies to visualize key components of the inflammatory cascade, from initiation to resolution.</gtr:title><gtr:parentPublicationTitle>Pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/994f32bbf7680bf25a2c8c6d4d577a6e"><gtr:id>994f32bbf7680bf25a2c8c6d4d577a6e</gtr:id><gtr:otherNames>Dorward DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0163-7258</gtr:issn><gtr:outcomeId>pm_16194_24_22627270</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3CBDE70-3543-4F70-B1EB-0B56A65E2D8A</gtr:id><gtr:title>Combined dysfunctions of immune cells predict nosocomial infection in critically ill patients.</gtr:title><gtr:parentPublicationTitle>British journal of anaesthesia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d7f730c06e18455fc8fcea0cdb66c2d"><gtr:id>6d7f730c06e18455fc8fcea0cdb66c2d</gtr:id><gtr:otherNames>Conway Morris A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-0912</gtr:issn><gtr:outcomeId>pm_16194_24_23756248</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E16CF07A-CD13-4B68-BA8F-C90B92244740</gtr:id><gtr:title>Trappin-2 promotes early clearance of Pseudomonas aeruginosa through CD14-dependent macrophage activation and neutrophil recruitment.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07c8ceef85565d89c1d1040e29103757"><gtr:id>07c8ceef85565d89c1d1040e29103757</gtr:id><gtr:otherNames>Wilkinson TS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>41589681452</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BABABCBC-48E1-46CC-ACFD-41A218A4BC80</gtr:id><gtr:title>Ventilator-associated pneumonia is characterized by excessive release of neutrophil proteases in the lung.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07c8ceef85565d89c1d1040e29103757"><gtr:id>07c8ceef85565d89c1d1040e29103757</gtr:id><gtr:otherNames>Wilkinson TS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>pm_16194_24_22911225</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>524F64B0-D7C6-44AE-BED6-0D7DD4042448</gtr:id><gtr:title>Monocytes control second-phase neutrophil emigration in established lipopolysaccharide-induced murine lung injury.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8ce3ba620de702c23f727037840690f"><gtr:id>b8ce3ba620de702c23f727037840690f</gtr:id><gtr:otherNames>Dhaliwal K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_16194_24_22822022</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFC3F624-AD10-4F76-9EFA-3B6155F92F32</gtr:id><gtr:title>Safe and efficient in vitro and in vivogene delivery: tripodal cationic lipids with programmed biodegradability</gtr:title><gtr:parentPublicationTitle>J. Mater. Chem.</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdffa356b4e030994b5d63c62e890fe4"><gtr:id>bdffa356b4e030994b5d63c62e890fe4</gtr:id><gtr:otherNames>Unciti-Broceta A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>ENEGuD6RAJR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67303E98-4708-43BC-8B3F-723DAEC56228</gtr:id><gtr:title>Screening of a combinatorial homing peptide library for selective cellular delivery.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16c1304c2d6f94d8298b4190539688bf"><gtr:id>16c1304c2d6f94d8298b4190539688bf</gtr:id><gtr:otherNames>Svensen N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>hCifCnGVYVu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0387CADB-D072-4198-88D5-A7BA9BFE6212</gtr:id><gtr:title>Far red and NIR dye-peptoid conjugates for efficient immune cell labelling and tracking in preclinical models</gtr:title><gtr:parentPublicationTitle>MedChemComm</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8ce3ba620de702c23f727037840690f"><gtr:id>b8ce3ba620de702c23f727037840690f</gtr:id><gtr:otherNames>Dhaliwal K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>bxgqbn1DMW1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C3FBE66-2AAB-4DCB-9AE4-B25386EE6294</gtr:id><gtr:title>C5a mediates peripheral blood neutrophil dysfunction in critically ill patients.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d7f730c06e18455fc8fcea0cdb66c2d"><gtr:id>6d7f730c06e18455fc8fcea0cdb66c2d</gtr:id><gtr:otherNames>Conway Morris A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>23F50F556A2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>365F195C-65DA-4ED5-BC6C-7DA94DAA6320</gtr:id><gtr:title>In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humans.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/639818e9f9cba4f7b25b4e09e9a01680"><gtr:id>639818e9f9cba4f7b25b4e09e9a01680</gtr:id><gtr:otherNames>Richards JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1941-9651</gtr:issn><gtr:outcomeId>pm_16194_24_22787016</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAFFBDE5-5AD8-4F69-B46F-79B13BD75397</gtr:id><gtr:title>Pulmonary and systemic effects of mononuclear leukapheresis.</gtr:title><gtr:parentPublicationTitle>Vox sanguinis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16a49a966ece60a2c40d9686bc38c8a3"><gtr:id>16a49a966ece60a2c40d9686bc38c8a3</gtr:id><gtr:otherNames>Barr L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0042-9007</gtr:issn><gtr:outcomeId>pm_16194_24_22497581</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA455F75-B87B-44A9-AD2A-43B112A1676B</gtr:id><gtr:title>A novel subpopulation of monocyte-like cells in the human lung after lipopolysaccharide inhalation.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2829c4cc11fbdc037ce0c865e466528"><gtr:id>a2829c4cc11fbdc037ce0c865e466528</gtr:id><gtr:otherNames>Brittan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>pm_16194_24_22267753</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>769D2C7E-82BF-4752-8A84-69D8CC3010B9</gtr:id><gtr:title>Multi-modal molecular imaging approaches to detect primary cells in preclinical models.</gtr:title><gtr:parentPublicationTitle>Faraday discussions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8ce3ba620de702c23f727037840690f"><gtr:id>b8ce3ba620de702c23f727037840690f</gtr:id><gtr:otherNames>Dhaliwal K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1359-6640</gtr:issn><gtr:outcomeId>Tjzq9AdBFBA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78F3DA54-B735-4A99-A242-654CAE64B0E4</gtr:id><gtr:title>Dunking doughnuts into cells--selective cellular translocation and in vivo analysis of polymeric micro-doughnuts.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96c3d33396ba0482031bce9466d27a95"><gtr:id>96c3d33396ba0482031bce9466d27a95</gtr:id><gtr:otherNames>Alexander L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>36A50554733</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D40D736-B985-45DE-91E6-82AC2E266D5C</gtr:id><gtr:title>Macrophage/monocyte depletion by clodronate, but not diphtheria toxin, improves renal ischemia/reperfusion injury in mice.</gtr:title><gtr:parentPublicationTitle>Kidney international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7871eeac6beee38c1dd69a1e1093f07"><gtr:id>f7871eeac6beee38c1dd69a1e1093f07</gtr:id><gtr:otherNames>Ferenbach DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0085-2538</gtr:issn><gtr:outcomeId>pm_16194_24_22673886</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90D93657-1990-48C8-BF19-6A60B98D55CB</gtr:id><gtr:title>Surface-enhanced Raman scattering in cancer detection and imaging.</gtr:title><gtr:parentPublicationTitle>Trends in biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f6d51c11279fc76c6170807af338f5d8"><gtr:id>f6d51c11279fc76c6170807af338f5d8</gtr:id><gtr:otherNames>Vendrell M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0167-7799</gtr:issn><gtr:outcomeId>pm_16194_24_23416096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1CFD8E7-2836-4D48-B2D3-ABC187F01198</gtr:id><gtr:title>Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumonia.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d7f730c06e18455fc8fcea0cdb66c2d"><gtr:id>6d7f730c06e18455fc8fcea0cdb66c2d</gtr:id><gtr:otherNames>Conway Morris A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>E3740A5B028</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE49201C-9FF4-434B-ABFF-F3A0A4D9E149</gtr:id><gtr:title>Pain in neonates during screening for retinopathy of prematurity using binocular indirect ophthalmoscopy and wide-field digital retinal imaging: a randomised comparison.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood. Fetal and neonatal edition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d712de59a5ada7c26b2bbf06f9ac2fe4"><gtr:id>d712de59a5ada7c26b2bbf06f9ac2fe4</gtr:id><gtr:otherNames>Dhaliwal CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1359-2998</gtr:issn><gtr:outcomeId>9CB1C19038B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC5D3B80-1B33-41D2-85BD-001203E77E77</gtr:id><gtr:title>Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b076b758610197602b59e94305d6c16"><gtr:id>5b076b758610197602b59e94305d6c16</gtr:id><gtr:otherNames>Farnworth SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>31EB75E46A9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57DAAE0F-289E-46E0-BC84-3B8E9BD783A2</gtr:id><gtr:title>Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/482af3eb67f4ca194e8027d61bd41d29"><gtr:id>482af3eb67f4ca194e8027d61bd41d29</gtr:id><gtr:otherNames>Gibbons MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>iFDAhxHVZyG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01C20FB2-2C5A-4955-8F61-2F3A27764EED</gtr:id><gtr:title>Highly specific, multi-branched fluorescent reporters for analysis of human neutrophil elastase.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18f288c92165e764eefc2343660d3bdc"><gtr:id>18f288c92165e764eefc2343660d3bdc</gtr:id><gtr:otherNames>Avlonitis N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>pm_16194_24_23715090</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>644909C6-D53E-4D9E-A6DA-B288B1DD3B7F</gtr:id><gtr:title>Cyclophilin A is a damage-associated molecular pattern molecule that mediates acetaminophen-induced liver injury.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0657e0f67428a9fd42aaeab3b2c965da"><gtr:id>0657e0f67428a9fd42aaeab3b2c965da</gtr:id><gtr:otherNames>Dear JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>Yfyug4cEvRu</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601401</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>